The genetics involved in CSOM are unknown, but the over 300 million people affected worldwide are unlikely to have gain-of-function mutations; instead, they are likely to have normally functioning NLRP3 inflammasomes. This evidence concerns the gene NLRP3 and chronic purulent otitis media.